These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35051007)

  • 1. Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction.
    Lee CL; Jhang JF; Jiang YH; Kuo HC
    Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury.
    Chen SF; Jiang YH; Jhang JF; Kuo HC
    Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions.
    Lee YK; Kuo HC
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31450851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic outcome and quality of life between urethral and detrusor botulinum toxin treatment for patients with spinal cord lesions and detrusor sphincter dyssynergia.
    Kuo HC
    Int J Clin Pract; 2013 Oct; 67(10):1044-9. PubMed ID: 24073977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions.
    Jiang YH; Jhang JF; Chen SF; Kuo HC
    Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant Detrusor and External Urethral Sphincter Botulinum Toxin-A Injections in Male Spinal Cord Injury Patients with Detrusor Overactivity and Detrusor Sphincter Dyssynergia.
    Huang YH; Chen SL
    J Rehabil Med; 2022 Mar; 54():jrm00264. PubMed ID: 35174865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia.
    Chen CY; Liao CH; Kuo HC
    Spinal Cord; 2011 May; 49(5):659-64. PubMed ID: 21243000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Video-Urodynamic Characteristics and Predictors of Switching from Botulinum Neurotoxin a Injection to Augmentation Enterocystoplasty in Spinal Cord Injury Patients.
    Lin CC; Kuo HC
    Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
    Kuo HC
    Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin as a new therapy option for voiding disorders: current state of the art.
    Leippold T; Reitz A; Schurch B
    Eur Urol; 2003 Aug; 44(2):165-74. PubMed ID: 12875934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction.
    Kao YL; Huang KH; Kuo HC; Ou YC
    Toxins (Basel); 2019 Dec; 11(12):. PubMed ID: 31847090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Satisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesion.
    Kuo HC
    Neurourol Urodyn; 2008; 27(8):793-6. PubMed ID: 18508331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Factors for a Successful Treatment Outcome in Patients with Different Voiding Dysfunction Subtypes Who Received Urethral Sphincter Botulinum Injection.
    Kao YL; Ou YC; Tsai KJ; Kuo HC
    Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder.
    Chen SF; Chang CH; Kuo HC
    Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27249005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Efficacy of Urethral Sphincteric Botulinum Toxin Injections for Female Sphincter Dysfunctions and a Search for Predictive Factors.
    Ou YC; Huang KH; Jan HC; Kuo HC; Kao YL; Tsai KJ
    Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34199493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
    Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
    J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of botulinum toxin A injections in spinal cord injury patients with detrusor overactivity and detrusor sphincter dyssynergia.
    Huang M; Chen H; Jiang C; Xie K; Tang P; Ou R; Zeng J; Liu Q; Li Q; Huang J; Huang T; Zeng W
    J Rehabil Med; 2016 Oct; 48(8):683-687. PubMed ID: 27563834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum Toxin A Injection for Autonomic Dysreflexia-Detrusor Injection or Urethral Sphincter Injection?
    Chow PM; Kuo HC
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity.
    Chen SF; Kuo HC
    J Formos Med Assoc; 2015 Jul; 114(7):583-9. PubMed ID: 24262922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.